C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
12/2009
12/10/2009	US20090306063 Oxadiazoanthracene Compounds For The Treatment Of Diabetes
12/10/2009	CA2722723A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
12/09/2009	EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009	CN101600682A Process for making 3-substituted 2-amino-5-halobenzamides
12/09/2009	CN101595871A Dichloro-acetyl benzo-oxazine type herbicide safener and synthetic method thereof
12/08/2009	US7629460 Dihydropteridione derivatives, process for their manufacture and their use as medicament
12/03/2009	WO2009145360A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
12/03/2009	US20090299063 Inhibitors for Extracellular Signal-Regulated Kinase Docking Domains and Uses Therefor
12/03/2009	US20090299061 Fluorescence assays with improved sensitivity
12/03/2009	US20090298828 Alkoxyalkyl-Substituted Cyclic Keto-Enols
12/03/2009	US20090298819 Compositions, Synthesis, And Methods Of Using Piperazine Based Antipsychotic Agents
12/03/2009	CA2725110A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
12/02/2009	EP2125759A2 Method for producing betamimetics
12/02/2009	EP2125750A2 Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/02/2009	EP2125698A1 Deuterated venlafaxines and 0-desmethylvenlafaxines with serotoninergic and /or norepinephrinergic activity
12/02/2009	EP1446390B1 Photochromic oxazine compounds and methods for their manufacture
12/02/2009	EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents
12/02/2009	CN100564377C Substituted 4H-chromenes and analogs as activators of caspase and inducers of apoptosis and use thereof
12/02/2009	CN100564341C A method for inhibiting polymerization of (meth) acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor
12/01/2009	US7626042 O-substituted hydroxyaryl derivatives
12/01/2009	US7626018 Enzymatic substrates derived from phenoxazinone and their use as developer in detection of microorganisms with peptidase activity
12/01/2009	CA2508262C Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
11/2009
11/26/2009	US20090291953 Pharmaceutical salts of reboxetine
11/26/2009	US20090291948 Sulfonamide peri-substituted bicyclics for occlusive artery disease
11/26/2009	US20090291947 Proline analogs as ligands for cannabinoid receptors
11/26/2009	US20090291945 Cysteine protease inhibitors
11/25/2009	EP2123643A1 Novel prophylactic and/or therapeutic agent for diabetic neuropathy
11/25/2009	EP2123642A1 Novel prophylactic and/or therapeutic agent for neurogenic pain
11/25/2009	EP2122739A1 Nitroxides for lithium-ion batteries
11/25/2009	CN100562513C Benzamide derivative or salt thereof
11/24/2009	US7622497 Such as -(Morpholin-4-yl)-ethyl gambogate; 2-Dimethylaminoethyl gambogate; N-[3-(4-Methyl-piperazin-1-yl)-propyl]gambogamide;N-(3-Morpholin-4-yl-propyl)gambogamide; Methyl 37,38-Dihydroxy-gambogate; Methyl 37,38-Dihydroxy-9,10-dihydro-10-morpholinyl-gambogate; anticarcinogenic agent
11/24/2009	US7622467 Aryl aniline derivatives as β2 adrenergic receptor agonists
11/24/2009	CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
11/19/2009	WO2009105218A3 Propiophenone derivatives
11/19/2009	US20090286977 Method for producing an amine
11/19/2009	US20090286776 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/19/2009	US20090286775 Bicyclic Derivatives as P38 Kinase Inhibitors
11/18/2009	EP1991534B1 Process for the preparation of 2-(4-hydroxy-3-morfolynil)-2-cyclohexenone
11/17/2009	CA2521950C Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
11/12/2009	WO2009137413A1 Therapeutic cyclopentane derivatives
11/12/2009	WO2009137412A1 Therapeutic compounds
11/12/2009	WO2009137411A1 Therapeutic compounds
11/12/2009	WO2009117467A3 Therapeutic compounds
11/12/2009	US20090281309 Method for producing 2-oxazoline analogue or 1,3-oxazine analogue
11/12/2009	US20090281096 Cyclothiocarbamate derivatives as progesterone receptor modulators
11/12/2009	US20090281085 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity
11/12/2009	US20090280331 Phosphorus-containing benzoxazine compound, process for production thereof, curable resin composition, cured article, and laminate plate
11/12/2009	CA2728227A1 Therapeutic cyclopentane derivatives
11/11/2009	EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone
11/11/2009	CN101578274A Method for producing betamimetics
11/11/2009	CN100558716C Benzoxazine resin intermediate, resin and solidified matter and their preparing method and use
11/11/2009	CN100558428C Calcitonin gene related peptide receptor antagonists
11/11/2009	CN100558409C Thiotungstate analogues and uses thereof
11/10/2009	US7615552 Fused heterocyclic compounds
11/10/2009	US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/10/2009	US7615549 Substituted pyrrolidinones, their manufacture and their use as medicaments
11/10/2009	CA2410862C Factor viia inhibitory (thio)urea derivatives, their preparation and their use
11/05/2009	WO2009133538A1 Process for the preparation of efavirenz
11/05/2009	WO2009102460A3 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/05/2009	WO2009006243A8 Processes for preparing bicyclic oxazine carboxaldehyde and beta-lactamase inhibitors
11/05/2009	US20090275714 New Ruthenium Complexes as Catalysts for Metathesis Reactions
11/05/2009	US20090275583 Antiviral compounds and use thereof
11/05/2009	US20090275565 Substituted aralkyl derivatives
11/05/2009	US20090275536 Antibacterial Agents
11/03/2009	US7612063 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 4-oxo-4H-pyrido[3,2,1-kl]benzo[g]-phenoxazine for example; Tumor suppression agents with reduced side effects; anticancer
11/03/2009	CA2442423C Therapeutic drug for psychoneurotic disorders
11/03/2009	CA2360767C Tricyclic benzodiazepines as vasopressin receptor antagonists
10/2009
10/29/2009	WO2009132093A2 Substituted arylcyclopentenes as therapeutic agents
10/29/2009	WO2009131977A1 Therapeutic compounds
10/29/2009	WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009	WO2009129726A1 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture
10/29/2009	US20090270615 Method of preparing benzoxazines
10/29/2009	US20090270396 Therapeutic compounds
10/29/2009	US20090270395 EP4 Receptor Agonist, Compositions and Methods Thereof
10/29/2009	US20090270384 Morpholine dopamine agonists
10/29/2009	US20090270381 Non-steroidal progesterone receptor modulators
10/29/2009	US20090270380 3,4,5-Substituted Piperidines as Renin Inhibitors
10/29/2009	US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009	US20090270360 Dicarboxamide derivatives
10/29/2009	DE102007049630A1 New amide compounds used for therapy and/or prophylaxis of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy
10/29/2009	CA2731279A1 Therapeutic compounds
10/29/2009	CA2722403A1 Substituted arylcyclopentenes as therapeutic agents
10/29/2009	CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/28/2009	CN100554234C Clear photopolymerizable systems for the preparation of high thickness coatings
10/27/2009	CA2376355C N-heterocyclic derivatives as nos inhibitors
10/27/2009	CA2318976C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
10/22/2009	WO2009128395A1 Bone formation promoter comprising 2-aminophenol or derivative thereof as active ingredient
10/22/2009	WO2009128262A1 Quinolone derivative and use thereof
10/22/2009	WO2009101432A3 Process for preparing pyridone derivatives
10/22/2009	US20090264652 Method for producing an amine
10/22/2009	US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009	US20090264404 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders
10/21/2009	EP2109602A2 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
10/21/2009	EP1515724B1 Mitotic kinesin inhibitors
10/21/2009	CN101563347A Vasopressin V1a antagonists
10/21/2009	CN101560194A Method for synthesizing 1, 3-oxazine-2, 4-diketone compounds
10/20/2009	US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
10/20/2009	US7605165 Phenylalanine derivatives
10/20/2009	US7605111 Herbicides
10/20/2009	CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection

1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 112